Ashland Inc. (FRA:AHT)
Germany · Delayed Price · Currency is EUR | Market Cap | 2.59B +22.2% |
| Revenue (ttm) | 1.57B -7.2% |
| Net Income | -612.31M |
| EPS | -13.46 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 16.15 |
| Dividend | 1.43 (2.59%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | n/a |
| Open | 55.00 |
| Previous Close | 54.00 |
| Day's Range | 55.00 - 55.00 |
| 52-Week Range | 40.40 - 58.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 28, 2026 |
About Ashland
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemi... [Read more]
News
Ashland responds to investor presentation by Ancora Alternatives LLC
WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's...
Ashland price target raised to $72 from $66 at UBS
UBS raised the firm’s price target on Ashland (ASH) to $72 from $66 and keeps a Buy rating on the shares after Ancora disclosed an activist campaign focused on the…
Ancora Releases Presentation Highlighting the Opportunity for a Value-Maximizing, Competitive Sale Process at Ashland Inc.
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora”) today released a presentation (available here) detailing what it believes is a near-term opportunity...
Ancora built significant stake in Ashland, pushing for sale, Reuters reports
Activist Ancora Alternatives has built a significant stake in Ashland (ASH) and said it is ready to launch a proxy fight at the specialty chemicals company if there is not…
Ashland up 5% after report of Ancora pushing for sale
Shares of Ashland (ASH) are up about 5% to $60.59 following Reuters’ report of activist Ancora’s involvement.
Ancora pushing Ashland to pursue sale, Reuters reports
13:18 EDT Ancora pushing Ashland (ASH) to pursue sale, Reuters reports
Ashland appoints Entegris chair Bertrand Loy to board
Ashland (ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15. Loy currently serves as a director and the executive chair of Entegris (ENTG).
Ashland Board appoints Bertrand Loy as new director
WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026.
Ashland upgraded to Buy from Neutral at Seaport Research
Seaport Research analyst Michael Harrison upgraded Ashland (ASH) to Buy from Neutral with a $75 price target The company reported weaker than expected Q2 and reduced its fiscal 2026 guidance,…
Ashland board authorizes quarterly dividend
WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock whic...
Ashland price target lowered to $58 from $63 at Morgan Stanley
Morgan Stanley analyst Steven Haynes lowered the firm’s price target on Ashland (ASH) to $58 from $63 and keeps an Equal Weight rating on the shares.
Ashland price target lowered to $60 from $70 at Deutsche Bank
Deutsche Bank analyst David Begleiter lowered the firm’s price target on Ashland (ASH) to $60 from $70 and keeps a Buy rating on the shares.
Ashland price target lowered to $65 from $70 at JPMorgan
JPMorgan lowered the firm’s price target on Ashland (ASH) to $65 from $70 and keeps an Overweight rating on the shares.
Ashland Earnings Call Transcript: Q2 2026
Q2 results showed resilient demand and strong cash flow, but margins were pressured by operational disruptions at Calvert City and Hopewell. Updated 2026 guidance reflects stable core markets, ongoing innovation, and prudent management amid macro uncertainty.
Ashland Earnings release: Q2 2026
Ashland released its Q2 2026 earnings on April 29, 2026, summarizing the period's financial results.
Ashland Slides: Q2 2026
Ashland has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on April 29, 2026.
Ashland Quarterly report: Q2 2026
Ashland has published its Q2 2026 quarterly earnings report on April 29, 2026.
Ashland reports Q2 adjusted EPS 91c, consensus 94c
Reports Q2 revenue $482M, consensus $485.61M. “Ashland’s (ASH) second quarter results reflect commercial execution across much of the portfolio as we navigated a challenging operating environment with...
Ashland lowers FY26 revenue view to $1.84B-$1.87B from $1.84B-$1.91B
Consensus $1.85B. Lowers FY26 adjusted EBITDA view to $385M-$400M from $400M-$420M. The company said, “Ashland (ASH) is updating its full-year fiscal 2026 sales guidance to a range of $1,835 to…
Ashland reports second quarter fiscal 2026 results and updates full-year outlook
Sales of $482 million, up one percent from the prior-year quarter Income from continuing operations of $15 million, or $0.32 per diluted share Adjusted Income from Continuing Operations Excluding Inta...
Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast
WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2026 earnings release at approximately 5 p.m.
Ashland price target lowered to $65 from $70 at Mizuho
Mizuho lowered the firm’s price target on Ashland (ASH) to $65 from $70 and keeps an Outperform rating on the shares. The firm adjusted targets in the chemicals and packaging…
Ashland price target lowered to $56 from $70 at Argus
Argus analyst Bill Selesky lowered the firm’s price target on Ashland (ASH) to $56 from $70 and keeps a Buy rating on the shares. The company’s earnings have been hurt…
Ashland to implement pricing actions across product portfolio
Ashland (ASH) is implementing pricing actions across its life sciences, intermediates, personal care and specialty additives product portfolios globally in response to continued volatility in energy m...
Ashland implementing pricing actions across product portfolio
Ashland (ASH) is implementing pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives product portfolios globally in response to continued volatility in energy m...